CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,192,759
- in 6 filings, $5.2M under 10b5-1 plans
Net −$5,192,759. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-24 | PYOTT DAVID E I Director | Option exercise · Restricted Stock Units | −1,383 | 0 | ||
| 2026-03-20 | Neervannan Seshadri Chief Operating Officer | Sale 10b5-1 | −2,989 | $66.75 | $200K | 82,791 |
| 2026-03-19 | Lin Elizabeth Yeu Chief Medical Officer | Sale | −390 | $67.00 | $26K | 23,308 |
| 2026-03-19 | Wahl Bryan General Counsel | Sale | −4,231 | $67.00 | $283K | 63,959 |
| 2026-03-19 | Whitfield Dianne C. Chief Human Resources Officer | Sale | −4,174 | $67.00 | $280K | 35,028 |
| 2026-03-19 | Azamian Bobak R. President/CEO and Board Chair | Sale | −11,964 | $67.00 | $802K | 33,421 |
| 2026-03-19 | Neervannan Seshadri Chief Operating Officer | Sale | −4,589 | $67.00 | $307K | 85,780 |
| 2026-03-19 | Mottiwala Aziz Chief Commercial Officer | Sale | −4,440 | $67.00 | $297K | 61,480 |
| 2026-03-19 | Farrow Jeffrey S See Remarks | Sale | −2,186 | $67.00 | $146K | 43,316 |
| 2026-03-18 | Lin Elizabeth Yeu Chief Medical Officer | Sale | −379 | $68.71 | $26K | 23,698 |
| 2026-03-18 | Wahl Bryan General Counsel | Sale | −4,125 | $68.71 | $283K | 68,190 |
| 2026-03-18 | Whitfield Dianne C. Chief Human Resources Officer | Sale | −4,071 | $68.71 | $280K | 39,202 |
| 2026-03-18 | Azamian Bobak R. President/CEO and Board Chair | Sale | −11,667 | $68.71 | $802K | 45,385 |
| 2026-03-18 | Neervannan Seshadri Chief Operating Officer | Sale | −3,610 | $68.71 | $248K | 90,369 |
| 2026-03-18 | Mottiwala Aziz Chief Commercial Officer | Sale | −4,330 | $68.71 | $298K | 65,920 |
| 2026-03-18 | Farrow Jeffrey S See Remarks | Sale | −2,133 | $68.71 | $147K | 45,502 |
| 2026-03-17 | Lin Elizabeth Yeu Chief Medical Officer | Sale | −375 | $69.42 | $26K | 24,077 |
| 2026-03-17 | Wahl Bryan General Counsel | Sale | −4,084 | $69.42 | $284K | 72,315 |
| 2026-03-17 | Whitfield Dianne C. Chief Human Resources Officer | Sale | −4,029 | $69.42 | $280K | 43,273 |
| 2026-03-17 | Azamian Bobak R. President/CEO and Board Chair | Sale | −10,972 | $69.42 | $762K | 57,052 |
Page 4 of 13 · 257 trades